๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Serum-Zn-levels in prostatic cancer

โœ Scribed by Feustel, A. ;Wennrich, R. ;Schmidt, B.

Publisher
Springer
Year
1989
Tongue
English
Weight
179 KB
Volume
17
Category
Article
ISSN
0300-5623

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

CA-50 serum level in patients with prost
CA-50 serum level in patients with prostate cancer
โœ Marczyล„ska, A. ;Kulpa, J. ;Leล„ko, J. ;Bugajski, A. ;Wรณjcik, E. ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› Springer ๐ŸŒ English โš– 251 KB

CA-50 antigen is considered to be a generalized carcinoma-associated antigen. CA-50 serum levels were measured by solid phase radioimmunoassay using a specific monoclonal antibody. Sera of 49 patients with prostatic cancer of different clinical stages, 43 patients suffering from BPH, and 28 healthy

Serum lipid levels in benign prostatic h
Serum lipid levels in benign prostatic hyperplasia
โœ Murat Lekili; Talha MรผezzinoฤŸlu; Bekir Sami Uyanฤฑk; CoลŸkun Bรผyรผksu ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› Springer-Verlag ๐ŸŒ English โš– 231 KB
Serum prostatic acid-phosphatase levels
Serum prostatic acid-phosphatase levels in the male patients of a cancer-prevention clinic
โœ Emerson Day; Sai Hou Ying; Morton K. Schwartz; Willet F. Whitmore Jr.; Oscar Bod ๐Ÿ“‚ Article ๐Ÿ“… 1956 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 558 KB

N 1953 Fishniari arid Lernera suggested that I the inhibitory action of L-tartrate on acid phosphatase, which had been described by Abul-Fad1 and King, might be applied in the differentiation between the serum acid phosphatase of nonprostatic origin and that coming from the prostate. They devised a

Serum estrogen levels and prostate cance
Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested caseโ€“control study
โœ Song Yao; Cathee Till; Alan R. Kristal; Phyllis J. Goodman; Ann W. Hsing; Cather ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› Springer Netherlands ๐ŸŒ English โš– 190 KB

## Objective Finasteride reduces prostate cancer risk by blocking the conversion of testosterone to dihydrotestosterone. However, whether finasteride affects estrogens levels or change in estrogens affects prostate cancer risk is unknown. ## Methods These questions were investigated in a caseโ€“con